Treatment of chronic urticaria with ketotifen

Archives of Dermatology

Volumn 133, Issue 2, 1997, Pages 147-149

  Egan, Conleth A ^a   Rallis, Tena M ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ANTIHISTAMINIC AGENT; AZATADINE MALEATE; CROMOGLYCATE DISODIUM; CYCLOPHOSPHAMIDE; FLUOXETINE; HYDROCHLOROTHIAZIDE; HYDROXYZINE; KETOTIFEN; LEVOTHYROXINE SODIUM; METHYLPREDNISOLONE ACETATE; PREDNISONE; RANITIDINE; TERBUTALINE SULFATE;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DROWSINESS; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SEDATION; SKIN BIOPSY; TREATMENT FAILURE; URTICARIA; VERTIGO; XEROSTOMIA;

EID: 0031016960     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.2.147     Document Type: Article

References (14)

1. Grattan CEH, Francis DM, Slater NGP, Barlow RJ, Greaves MW. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992;339:1078-1080.
2. Cooper KD. Urticaria and angioedema: diagnosis and evaluation. J Am Acad Dermatol. 1991;25:166-176.
3. Champion RH. Urticaria. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology. 5th ed. Oxford, England: Blackwell Scientific Publications: 1992:1865.
4. Hide M, Francis DM, Grattan CEH, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328:1599-1604.
5. Leznoff A, Josse RG, Denburg J, Dolovich J. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol. 1983;119:636-640.
6. Grant SM, Goa KL, Fitton A, et al. Ketotifen: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs. 1990;40:412-448.
7. Craps L. Immunologic and therapeutic aspects of ketotifen. J Allergy Clin Immunol. 1985;76:389-393.
8. Morley J, Page CP, Mazzoni L, et al. Effects of ketotifen upon responses to platelet activating factor: a basis for asthma prophylaxis. Ann Allergy. 1986; 56:335-340.
9. Craps LP, Ney UM. Ketotifen: current views on its mechanism of action and their therapeutic implications. Respiration. 1984;45:411-421.
10. Tasaka K, Okamoto M. Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann Allergy. 1986;56: 464-469.
11. Riccardi VM. A controlled multiphase trial of ketotifen to minimize neuroflbroma-associated pain and itching. Arch Dermatol. 1993;129:577-581.
12. Esau S, del Carpio J, Martin JG. A comparison of the effects of ketotifen and clemastine on cutaneous and airway reactivity to histamine and allergen in atopic asthmatic subjects. J Allergy Clin Immunol. 1984;74:270-274.
13. Kuokkanen K. Comparison of a new antihistamine HC 20-511 with cyproheptadine (Periactin) in chronic urticaria. Acta Allergol. 1977;32:316-320.
14. Craps L, Ketotifen in the oral prophylaxis of bronchial asthma: a review. Pharmatherapeutica. 1981;3:18-35.